Transcat, Inc.
corporate_fare Company Profile
Transcat, Inc. (NASDAQ:TRNS) is a publicly traded company in the Industrial Applications And Services sector. Wiseek has independently scored 15 items for TRNS at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-11-03, rated 8/10. Across its 15 most recent items scored 7 or higher, the top rating is 9/10, with 9 rated 8 or above. Recent SEC coverage for TRNS spans 10-Q, 8-K, 144, 10-K.
Recent high-impact activity:
- Transcat Q2 FY27: Revenue Up 18% to $97.1M, But Material Weaknesses Persist
- Transcat Beats on Service Growth, Lifts Full-Year Organic Revenue Outlook
- Transcat Buys Southeastern Biomedical to Expand Calibration Channel
- Transcat Q1 Revenue Jumps 22% but Net Income Halves; Material Weaknesses Persist
- Transcat Q1 FY27: Service Revenue Jumps 27%, Adjusted EBITDA Climbs 19%, and Margins Keep Expanding
Financial Snapshot
Short Interest & Short Volume
2.43 days to coverFINRA reported short interest of 378,791 shares in TRNS as of the October 30, 2026 settlement, a 14.3% decrease from the prior period — about 2.4 days to cover at its recent average daily volume. On November 20, 2026, 57.5% of TRNS volume reported to FINRA trade-reporting facilities was marked short.
Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.
Dilution Risk
Low riskFiling-implied dilution signals for TRNS, detected from its recent SEC filings.
Resale Registration Filed · Final Holdback Shares Released
A filing-implied signal, not a realized share count. How Wiseek tracks dilution →